Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.25
Bid: 17.50
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 1.50 (8.571%)
Open: 18.25
High: 18.25
Low: 18.25
Prev. Close: 18.25
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix Health Raises GBP1 Million Through Share Issue

Fri, 17th Apr 2020 14:35

(Alliance News) - OptiBiotix Health PLC on Friday said it has raised GBP1 million through the placing of 2.5 million shares at 40 pence each.

Shares in the life sciences firm were trading 2.1% lower at 47.99p each on Friday afternoon in London.

OptiBiotix said certain directors subscribed for 128,750 shares in total, with Chief Executive Stephen O'Hara taking his stake in the company to 12% through the subscription for 62,500 shares.

The company said the new funds will be used to pursue opportunities corporate and large retail partners in relation to its SweetBiotix products, as well as other commercial opportunities. It added that it intends to launch its products in China, the US, and India, expand its presence in the US, and scale up additional SweetBiotix products.

SweetBiotix is OptiBiotix's sweetener. The company said the study of SweetBiotix found that it improved "the number and activity of bacterial species typically associated with good gut health when compared to current natural sweeteners".

Following admission of the new shares, the company will have 87.9 million shares in issue.

"The company has received a high level of partner interest in its technology and products across new application areas and new territories that have the potential for significant value uplift. It has become clear that there is a window of opportunity to exploit interest in SweetBiotix across multiple applications and the potential for listing existing products with major retailers in large international markets, said O'Hara.

"This may not be achievable in the short term with the current resources. Rather than delay these opportunities until OptiBiotix has sufficient revenues to cover costs, the board has decided to take additional funds to capitalise on these growth opportunities and build shareholder value," he added.

By Ife Taiwo; ifetaiwo@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
7 May 2019 12:13

OptiBiotix inks LPLDL deal with Spain's IENP

(Sharecast News) - Life sciences business OptiBiotix Health announced on Tuesday that its wholly-owned subsidiary ProBiotix Health has signed a license agreement with Instituto Español de Nutrición Personalizada (IENP) for the use of 'lactobacillus plantarum' (LPLDL) in personalised food supplements in Spain.

Read more
29 Apr 2019 13:04

OptiBiotix Expects Further Growth After Annual Revenue Multiplies

LONDON (Alliance News) - OptiBiotix Health PLC on Monday reported a significant growth in revenue in its most recently ended financial year as it is on track to become a commercial life sciences a

Read more
24 Apr 2019 11:28

OptiBiotix to launch SlimBiome Medical in UK market this month

(Sharecast News) - Life sciences business OptiBiotix Health announced the launch of its weight management product 'SlimBiome Medical' to the UK market on Wednesday.

Read more
11 Apr 2019 11:16

OptiBiotix partner gets approval to make SlimBiome in India

(Sharecast News) - OptiBiotix Health announced on Thursday that it has received a licence from the Food Standards and Safety Authority India (FSSAI) for its weight management product 'SlimBiome' to be manufactured in the country.

Read more
9 Apr 2019 09:58

OptiBiotix Inks SlimBiome Distribution Pact For Bulgaria

LONDON (Alliance News) - OptiBiotix Health PLC on Tuesday said it has entered into a three-year deal with an undisclosed company to distribute and commercialise SlimBiome Medical in is used for a

Read more
20 Mar 2019 07:41

OptiBiotix inks deal with DKSH for Italy and Spain markets

(Sharecast News) - Life sciences company OptiBiotix Health has entered into an exclusive agreement with DKSH International to distribute its 'SlimBiome' proprietary weight management technology in Italy and Spain, it announced on Wednesday.

Read more
15 Mar 2019 08:16

Optibiotix Health expands international reach through supply agreement

(Sharecast News) - OptiBiotix Health on Friday extended a supply agreement to broaden the supply of cholesterol-lowering capsules into Germany and several other countries.

Read more
13 Mar 2019 16:08

OptiBiotix Health Secures GBP57,000 Following Warrants Exercise (ALLISS)

LONDON (Alliance News) - OptiBiotix Health PLC on Wednesday said it has raised GBP56,666 following an exercise of warrants.The life sciences company said 708,325 warrants were exercised at

Read more
21 Feb 2019 11:38

US FDA Finds OptiBiotix Health Cholesterol Probiotic Safe For Use

LONDON (Alliance News) - OptiBiotix Health PLC on Thursday said the US FDA assigned a GRAS designation to its cholesterol and blood pressure reducing probiotic strain.The Lactobacillus by a

Read more
21 Feb 2019 11:07

OptiBiotix up as LPLDL gets 'safe' status in US

(Sharecast News) - Life sciences firm OptiBiotix Health confirmed on Thursday that its wholly-owned subsidiary ProBiotix Health has had its cholesterol and blood pressure reducing 'Lactobacillus plantarum LPLDL' probiotic strain determined as 'Generally Recognized As Safe' (GRAS) by an independent expert GRAS panel in the United States.

Read more
13 Feb 2019 08:46

Optibiotix revenues soar in second half

(Sharecast News) - Optibiotix Health's annual income soared in its last trading year as the healthy food additive maker continued to commercialise its products and grow sales.

Read more
11 Feb 2019 12:32

OptiBiotix gains foothold in Japan with distibution deal

(Sharecast News) - Optibiotix Health on Monday signed an agreement appointing EIWA Trading Co. as its exclusive distributor for its cholesterol and blood pressure-reducing probiotic strain LPLDL in Japan.

Read more
11 Feb 2019 10:03

OptiBiotix Health Appoints EIWA To Distribute LPLDL Products In Japan

LONDON (Alliance News) - Life sciences company Optibiotix Health PLC said on Monday it has appointed EIWA Trading Co Ltd as the exclusive distributor for its LPLDL products in Japan.In EIWA

Read more
7 Feb 2019 10:40

OptiBiotix Health Inks Commercial Deal Covering Baltics With Biolat

LONDON (Alliance News) - OptiBiotix Health PLC on Thursday said it has entered a three-year supply agreement with Latvia-based firm Biolat JSC covering Estonia, Latvia and is a life sciences firm

Read more
9 Jan 2019 08:56

OptiBiotix extends CholBiome sales channel to Russia and Kazakhstan

(Sharecast News) - OptiBiotix Health on Wednesday entered into a three-year distribution agreement for its own-brand CholBiome products in Russia and Kazakhstan.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.